Jpmorgan Chase & CO Enochian Biosciences Inc Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 353,833 shares of ENOB stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
353,833
Previous 93,010 280.42%
Holding current value
$1.63 Million
Previous $427,000 281.03%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
N/A
260,823 Added 280.42%
353,833 $1.63 Million
Q3 2024

Dec 26, 2024
BUY
N/A
72,230 Added 347.59%
93,010 $427,000
Q3 2024

Nov 08, 2024
BUY
N/A
72,230 Added 347.59%
93,010 $427,000
Q2 2024

Dec 26, 2024
SELL
N/A
-72,230 Reduced 77.66%
20,780 $95,000
Q2 2024

Aug 12, 2024
SELL
N/A
-99,568 Reduced 82.73%
20,780 $95,000
Q1 2024

Dec 26, 2024
BUY
N/A
27,338 Added 29.39%
120,348 $553,000
Q1 2024

May 10, 2024
BUY
N/A
90,529 Added 303.6%
120,348 $553,000
Q4 2023

Dec 26, 2024
SELL
$4.3 - $4.7 $271,721 - $296,997
-63,191 Reduced 67.94%
29,819 $137,000
Q4 2023

Feb 12, 2024
BUY
$4.3 - $4.7 $128,221 - $140,149
29,819 New
29,819 $137,000
Q2 2023

Aug 11, 2023
SELL
$0.4 - $1.3 $3,204 - $10,415
-8,012 Reduced 52.93%
7,126 $4,000
Q1 2023

May 18, 2023
BUY
$0.91 - $1.31 $13,775 - $19,830
15,138 New
15,138 $13,000
Q4 2022

Feb 13, 2023
BUY
$1.03 - $2.13 $639 - $1,322
621 Added 5.88%
11,186 $12,000
Q2 2022

Aug 11, 2022
BUY
$1.93 - $8.73 $20,390 - $92,232
10,565 New
10,565 $20,000
Q4 2021

Feb 10, 2022
SELL
$6.71 - $12.55 $67 - $125
-10 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$4.56 - $7.88 $45 - $78
10 New
10 $0

Others Institutions Holding ENOB

# of Institutions
58
Shares Held
19M
Call Options Held
41.4K
Put Options Held
49.2K
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email